Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people starting Wegovy notice warmth, flushing or a feeling of overheating, particularly in the hours after an injection. It is not listed as one of the most common side effects, but it does happen, and it tends to unsettle people who weren't expecting it. Wegovy (semaglutide) is a prescription-only medicine licensed for weight management in UK adults, and any side effects you experience should be discussed with your prescriber. The NHS medicines guidance on semaglutide sets out the full side-effect profile, and this page explains what the evidence says about heat and temperature changes specifically.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's a Tuesday evening, you've done your weekly Wegovy injection, and half an hour later you feel a wave of warmth across your face and chest. You're not ill. You haven't changed anything else. This is the moment a lot of people reach for their phone and search.
What's likely happening is a brief vasodilatory response (blood vessels widening) as semaglutide begins to act. GLP-1 receptors are found not just in the gut and brain but in blood vessels and the cardiovascular system. When those receptors are activated, some people experience a transient flush. It typically passes within an hour or two and is not a sign that something has gone wrong.
It can also coincide with nausea, which itself redirects blood flow and can produce sweating and a clammy warmth. The two sensations can be hard to separate. If you want to understand the fuller picture of how Wegovy makes you feel in the early weeks, the pattern of GI effects alongside these temperature changes is worth reading about together.
Some people also notice they feel warm after eating on Wegovy, because gastric emptying slows and digestion becomes more prolonged. The thermal effect of food (the gentle rise in body temperature that follows a meal) may linger longer than usual.
The STEP 1 trial, published in the New England Journal of Medicine, enrolled around 1,900 adults and tracked side effects systematically over 68 weeks. Gastrointestinal symptoms (nausea, diarrhoea, vomiting, constipation) dominated the adverse event tables. Flushing was not in the primary safety findings, which means it occurred below the threshold for common classification (generally set at affecting more than one in ten participants).
That doesn't make it rare or imagined. In pooled clinical trial data for semaglutide, flushing does appear, most often in the context of cardiovascular monitoring. Hot flushes, separate from simple warmth, have been reported, and there is some overlap with sweating episodes that accompany nausea.
Worth noting: if you are a woman in perimenopause or menopause, distinguishing a Wegovy-related flush from a hormonal hot flush is genuinely difficult. The timing relative to your injection and any concurrent GI symptoms can help. This is something worth mentioning to your prescriber at your next review, especially if the flushes are frequent or disruptive. Our clinical team reviews each patient individually, so changes in your experience of side effects can always be raised.
If you're curious whether the opposite is also possible, some patients report feeling cold on Wegovy as their body composition shifts, which illustrates how variable temperature perception can be on this treatment.
Most warmth or flushing on Wegovy is benign and brief. There are, however, situations where you should seek medical help the same day rather than wait it out.
Severe abdominal pain that spreads toward your back (with or without vomiting) should be assessed urgently. This is the pattern associated with acute pancreatitis, and the MHRA highlighted it as a known but infrequent serious risk in a Drug Safety Update published in January 2026. Pancreatitis can produce systemic symptoms including sweating and a hot, unwell feeling, so if your warmth comes with that kind of pain, it is not a flushing episode.
Similarly, a rash or hives alongside flushing could indicate an allergic reaction, which requires prompt attention. Rapid heartbeat or palpitations combined with warmth and dizziness should also be assessed rather than monitored at home.
For most people, though, the warm flush after an injection is one of those things that settles within a few weeks as the body adjusts. Keeping a simple note (time after injection, how long it lasted, any other symptoms) gives your prescriber something concrete to work with, and it's also worth reading about whether Wegovy can affect your mood and whether it can cause feelings of physical weakness, since these sometimes overlap with how people describe the post-injection period. You can also report unexpected or troubling reactions through the MHRA Yellow Card scheme, which exists precisely for this purpose.
If you'd like to read more about Wegovy's overall side-effect and tolerance profile, our Wegovy overview page covers the full picture. And if you're thinking about whether this treatment is right for you at all, how much weight Wegovy typically produces is a good place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.